Target Healthcare REIT (LON:THRL – Get Free Report) crossed above its 50 day moving average during trading on Thursday. The stock has a 50 day moving average of GBX 112.15 and traded as high as GBX 116.80. Target Healthcare REIT shares last traded at GBX 112.40, with a volume of 63,241,629 shares changing hands.
Wall Street Analyst Weigh In
Separately, Jefferies Financial Group reiterated a “hold” rating and set a GBX 101 target price on shares of Target Healthcare REIT in a research report on Wednesday, August 5th. One equities research analyst has rated the stock with a Hold rating, According to data from MarketBeat, Target Healthcare REIT has a consensus rating of “Hold” and a consensus target price of GBX 101.
Check Out Our Latest Stock Report on THRL
Target Healthcare REIT Price Performance
Target Healthcare REIT (LON:THRL – Get Free Report) last released its quarterly earnings results on Wednesday, September 23rd. The company reported GBX 13.32 EPS for the quarter. Target Healthcare REIT had a net margin of 114.60% and a return on equity of 11.03%. As a group, equities research analysts expect that Target Healthcare REIT will post 6.2219101 earnings per share for the current year.
About Target Healthcare REIT
Our investment objective is to provide shareholders with an attractive level of income together with the potential for capital and income growth, from a portfolio of UK care homes, diversified by tenant, geography, and resident payment profile. We only invest in modern, purpose-built homes.
Further Reading
- Five stocks we like better than Target Healthcare REIT
- 3 Income Stocks Under $30 That Yield More Than the 10-Year Treasury Note
- 3 AI Winners, 3 Very Different Paths to Higher Margins
- Plexus Is Booming—But Can the Growth Story Last?
- Conagra’s Turnaround Is Starting to Show Up in the Numbers
Receive News & Ratings for Target Healthcare REIT Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Target Healthcare REIT and related companies with MarketBeat.com's FREE daily email newsletter.
